EDAP TMS SA -ADR (EDAP) Stock Fundamental Analysis
USA - NASDAQ:EDAP - US2683111072 - ADR
2.35 USD
-0.03 (-1.26%)
Taking everything into account, EDAP scores 2 out of 10 in our fundamental rating. EDAP was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of EDAP have multiple concerns. While showing a medium growth rate, EDAP is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
EDAP had negative earnings in the past year.
In the past year EDAP has reported a negative cash flow from operations.
EDAP had negative earnings in 4 of the past 5 years.
In multiple years EDAP reported negative operating cash flow during the last 5 years.
1.2 Ratios
EDAP has a Return On Assets (-30.75%) which is comparable to the rest of the industry.
EDAP has a Return On Equity of -75.53%. This is comparable to the rest of the industry: EDAP outperforms 41.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.75% | ||
| ROE | -75.53% | ||
| ROIC | N/A |
ROA(3y)-16.04%
ROA(5y)-10.06%
ROE(3y)-29.27%
ROE(5y)-18.58%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EDAP's Gross Margin of 42.48% is on the low side compared to the rest of the industry. EDAP is outperformed by 64.02% of its industry peers.
EDAP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for EDAP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-2.4%
2. Health
2.1 Basic Checks
EDAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EDAP has been increased compared to 1 year ago.
EDAP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EDAP has a worse debt to assets ratio.
2.2 Solvency
A Debt/Equity ratio of 0.26 indicates that EDAP is not too dependend on debt financing.
EDAP has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACC7.62%
2.3 Liquidity
A Current Ratio of 1.51 indicates that EDAP should not have too much problems paying its short term obligations.
EDAP's Current ratio of 1.51 is on the low side compared to the rest of the industry. EDAP is outperformed by 74.60% of its industry peers.
EDAP has a Quick Ratio of 1.05. This is a normal value and indicates that EDAP is financially healthy and should not expect problems in meeting its short term obligations.
EDAP's Quick ratio of 1.05 is on the low side compared to the rest of the industry. EDAP is outperformed by 74.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
EDAP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.66%.
EDAP shows a small growth in Revenue. In the last year, the Revenue has grown by 1.07%.
EDAP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.38% yearly.
EPS 1Y (TTM)-5.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.25%
Revenue 1Y (TTM)1.07%
Revenue growth 3Y13.31%
Revenue growth 5Y7.38%
Sales Q2Q%1.6%
3.2 Future
The Earnings Per Share is expected to grow by 18.58% on average over the next years. This is quite good.
The Revenue is expected to grow by 16.62% on average over the next years. This is quite good.
EPS Next Y-41.53%
EPS Next 2Y-17.33%
EPS Next 3Y4.48%
EPS Next 5Y18.58%
Revenue Next Year-6.7%
Revenue Next 2Y-5.12%
Revenue Next 3Y-0.19%
Revenue Next 5Y16.62%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
EDAP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EDAP. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.33%
EPS Next 3Y4.48%
5. Dividend
5.1 Amount
EDAP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:EDAP (10/27/2025, 3:17:52 PM)
2.35
-0.03 (-1.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners37.83%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap87.19M
Revenue(TTM)63.02M
Net Income(TTM)-21014000
Analysts77.78
Price Target5.88 (150.21%)
Short Float %0.08%
Short Ratio0.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.71%
Min EPS beat(2)-23.38%
Max EPS beat(2)7.96%
EPS beat(4)2
Avg EPS beat(4)5.27%
Min EPS beat(4)-23.38%
Max EPS beat(4)50.84%
EPS beat(8)2
Avg EPS beat(8)-29.7%
EPS beat(12)3
Avg EPS beat(12)-298.57%
EPS beat(16)6
Avg EPS beat(16)-203.29%
Revenue beat(2)1
Avg Revenue beat(2)-3.37%
Min Revenue beat(2)-12.67%
Max Revenue beat(2)5.94%
Revenue beat(4)2
Avg Revenue beat(4)-4.85%
Min Revenue beat(4)-15.73%
Max Revenue beat(4)5.94%
Revenue beat(8)3
Avg Revenue beat(8)-5.04%
Revenue beat(12)4
Avg Revenue beat(12)-4.02%
Revenue beat(16)6
Avg Revenue beat(16)-3.02%
PT rev (1m)0%
PT rev (3m)0.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-26.83%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.19 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.7 | ||
| P/tB | 2.96 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.8
Fwd EYN/A
FCF(TTM)-0.95
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS1.97
BVpS0.87
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.75% | ||
| ROE | -75.53% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.48% | ||
| FCFM | N/A |
ROA(3y)-16.04%
ROA(5y)-10.06%
ROE(3y)-29.27%
ROE(5y)-18.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-2.4%
F-Score3
Asset Turnover0.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 192.55% | ||
| Cap/Sales | 7.84% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.51 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | N/A |
F-Score3
WACC7.62%
ROIC/WACCN/A
Cap/Depr(3y)176.18%
Cap/Depr(5y)116.88%
Cap/Sales(3y)5.91%
Cap/Sales(5y)4.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.25%
EPS Next Y-41.53%
EPS Next 2Y-17.33%
EPS Next 3Y4.48%
EPS Next 5Y18.58%
Revenue 1Y (TTM)1.07%
Revenue growth 3Y13.31%
Revenue growth 5Y7.38%
Sales Q2Q%1.6%
Revenue Next Year-6.7%
Revenue Next 2Y-5.12%
Revenue Next 3Y-0.19%
Revenue Next 5Y16.62%
EBIT growth 1Y-6.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-9.58%
EBIT Next 3Y-1.85%
EBIT Next 5YN/A
FCF growth 1Y6.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.45%
OCF growth 3YN/A
OCF growth 5YN/A
EDAP TMS SA -ADR / EDAP FAQ
What is the fundamental rating for EDAP stock?
ChartMill assigns a fundamental rating of 2 / 10 to EDAP.
What is the valuation status of EDAP TMS SA -ADR (EDAP) stock?
ChartMill assigns a valuation rating of 0 / 10 to EDAP TMS SA -ADR (EDAP). This can be considered as Overvalued.
Can you provide the profitability details for EDAP TMS SA -ADR?
EDAP TMS SA -ADR (EDAP) has a profitability rating of 1 / 10.
What is the expected EPS growth for EDAP TMS SA -ADR (EDAP) stock?
The Earnings per Share (EPS) of EDAP TMS SA -ADR (EDAP) is expected to decline by -41.53% in the next year.